Cumulative incidence of hepatocellular carcinoma (HCC) by sum scores of each model at study entry.

<p>Classical model (Risk Model I, A), the model combining liver-related seromarkers without HBV seromarkers of HBeAg serostatus and serum HBV DNA level (Risk Model II, B), and the model combining liver-related seromarkers with HBV seromarkers (Risk Model III, C).